Wockhardt Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 15, 2014, inter-alia approved a scheme of Amalgamation for amalgamation/merger of following two wholly owned subsidiaries with the Company: 1. Wockhardt Biopharm Limited (WBL) and 2. Vinton Healthcare Limited (VHL) Further, as mentioned above, since WBL & VHL are wholly owned subsidiaries of the Company, no shares are proposed to be issued pursuant to the amalgamation. This scheme is subject to requisite approvals, including under Listing Agreement and by the Hon'ble High Courts. The amalgamation being of wholly owned subsidiaries into the Company, a specific dispensation will be sought from the Hon'ble High Courts from filing the application / petition by the Company and accordingly, the Company may not be required to file petition with the High Court. Wockhardt Ltd has informed BSE that the Hon'ble High Court of Bombay on March 20, 2015 sanctioned the Scheme of Amalgamation of two wholly owned subsidiaries viz. Wockhardt Biopharm Ltd and Vinton Healthcare Ltd with Wockhardt Ltd ('the Company'). The appointed date of the said scheme of amalgamation is April 01, 2014. The aforesaid scheme will be effective once the order of the High Court is filed with Registrar of Companies, Mumbai. (As Per BSE Announcement Dated on 23.03.2015)